Austrianova’s production facility has recently been inspected by the Food and Drug Administration of Thailand (Thai FDA). In it’s report, Thai FDA stated “the facility is built according to the pre-approved floor plan and is suitable for the manufacture of pharmaceutical products”. The main role of the Thai FDA is to protect consumer’s health, especially, to ensure safety, quality and efficacy of health products.
April 9th 2016: Austrianova’s production facility receives positive opinion from Thai FDA
by Waqas Tariq | Apr 9, 2016 | News Archive, Uncategorized | 2 comments
Go Guys Hoping to see pleasant results with CIAB and Pharmacyte inc after being an ongoing investor for a few years now. . Well done Carry on Autrianova and Team, Blessings to you all.
JC
Thanks!!!